MLA 0.00% 8.5¢ medical australia limited

2014 Result, page-2

  1. 1,046 Posts.
    lightbulb Created with Sketch. 40
    Agreed groberts, I think the synergies of medivet, cost cutting and improved focus OEM business will show through in the coming quarters. The key appts of sales and vet staff should assist in driving this. With revenue how it is and lumpiness of contracts there will still be some variability, but hopefully the first of many profits to come!

    Heaps of potential.

    Dyor etc...
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.